Deletion or knockdown of USP15 can activate an antioxidant response via upregulating the KEAP1-NRF2 AML in humans and mice, substantially negatively impacting the function and survival of leukemic progenitor cells [21]. Here, USP15 is linked to acute myeloid leukemia.